With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

Unlike the US, Europe or other developed markets, Mounjaro will have to be purchased out-of-pocket in India, as obesity is ...

Eli Lilly launches Mounjaro in India, targeting the $150B weight-loss market. The GLP-1 drug offers diabetes control & major ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Mounjaro (Tirzepatide), a groundbreaking GLP-1 receptor agonist targeting GIP receptors, is now available in India for ...

Zerodha CEO Nithin Kamath highlighted the transformative potential of weight-loss drugs Ozempic and Mounjaro, which help in ...

Novo will pay Hong Kong-based United Laboratories $200 million upfront for the drug, which combines three different ...

Impact of Trump’s tariffs on IT companies’ demand outlook, why kirana share in FMCG declining decoded, inward remittance data ...

Trump hinted that the US will impose a 25%+ tariff on pharmaceuticals after giving US companies time to build more ...

Is the world ready for this?" he said. On March 20, Bloomberg reported that Eli Lilly is set to launch its first weight-loss drug, Mounjaro—the likely equivalent of the weight-loss drug Ozempic in ...

CenterPoint Energy is offering energy-saving tips for customers this spring: •Use weatherstripping or caulk in areas where air may escape, such as around windows and doors •Block the sun during warmer ...

Trump considers tariffs on pharmaceuticals, potentially impacting imported APIs and finished drugs. Read more here.